June 30, 2008
The United States Anti-Doping Agency (USADA) announced today that Rebekkah Brunson, of Washington, D.C., an athlete in the sport of basketball, tested positive for a prohibited substance and accepted a public warning for her first offense. The doping offense involved the use of a prescribed medication under the care of a physician but without first seeking a therapeutic use exemption as required by the applicable rules.
Brunson tested positive for Salmeterol, a beta-2 agonist, on June 5, 2008. Salmeterol is prohibited under the rules of the Fédération Internationale de Basketball (FIBA) and USADA, both of which adopted the World Anti-Doping Code and the World Anti-Doping Agency’s (WADA) Prohibited List. Although Salmeterol is a prohibited substance under the applicable rules, an athlete who provides documentation in advance of competition, confirming the diagnosis of a valid medical need, may receive an exemption allowing the use of the substance. At the time of the test, Brunson did not have an exemption to use Salmeterol.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement. USADA is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.